- Home
- MYN vs TKNO Comparison
MYN vs TKNO Comparison
Compare MYN & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYN
- TKNO
- Stock Information
- Founded
- MYN 1992
- TKNO 1996
- Country
- MYN United States
- TKNO United States
- Employees
- MYN N/A
- TKNO N/A
- Industry
- MYN Finance Companies
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- MYN Finance
- TKNO Health Care
- Exchange
- MYN Nasdaq
- TKNO Nasdaq
- Market Cap
- MYN 358.2M
- TKNO 256.9M
- IPO Year
- MYN N/A
- TKNO 2021
- Fundamental
- Price
- MYN $9.24
- TKNO $4.23
- Analyst Decision
- MYN
- TKNO
- Analyst Count
- MYN 0
- TKNO 0
- Target Price
- MYN N/A
- TKNO N/A
- AVG Volume (30 Days)
- MYN 86.0K
- TKNO 224.0K
- Earning Date
- MYN 01-01-0001
- TKNO 08-07-2025
- Dividend Yield
- MYN 4.12%
- TKNO N/A
- EPS Growth
- MYN N/A
- TKNO N/A
- EPS
- MYN N/A
- TKNO N/A
- Revenue
- MYN N/A
- TKNO $38,923,000.00
- Revenue This Year
- MYN N/A
- TKNO $9.52
- Revenue Next Year
- MYN N/A
- TKNO $15.20
- P/E Ratio
- MYN N/A
- TKNO N/A
- Revenue Growth
- MYN N/A
- TKNO 11.40
- 52 Week Low
- MYN $8.47
- TKNO $4.00
- 52 Week High
- MYN $10.62
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- MYN 40.73
- TKNO 40.65
- Support Level
- MYN $9.20
- TKNO $4.22
- Resistance Level
- MYN $9.33
- TKNO $4.94
- Average True Range (ATR)
- MYN 0.08
- TKNO 0.28
- MACD
- MYN -0.01
- TKNO -0.01
- Stochastic Oscillator
- MYN 28.12
- TKNO 13.95
About MYN Blackrock MuniYield New York Quality Fund Inc.Common Stock
Blackrock Muniyield NY Quality FD, Inc is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.